课题基金 / 基金详情

Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease

Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
丹曲林对阿尔茨海默病的神经保护机制
批准号:
10227272
负责人:
HUAFENG WEI
金额:
$33.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-01 至 2023-12-31

项目摘要

项目成果

HUAFENG WEI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Coronavirus disease 2019 (COVID-19), a pandemic affecting millions of patients around the world, is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with no effective drug treatments. Both infection and transfection of virus in host cells require abnormally elevated Ca2+ concentrations in cytosol and endosome via overactivation of ryanodine receptors (RyRs) Ca2+ channel located on the membrane of the endoplasmic reticulum (ER). Dantrolene, an antagonist of RyRs, has been demonstrated to inhibit SARS- CoV-2-mediated host cell toxicity and damage. In the presence of RyRs overactivation and excessive and abnormal elevation of cytosolic and endosome Ca2+ concentrations, the spike proteins (S1, S2) of the virus play important roles in binding, fusion, and virus replication in the host cell, eventually leading to cell damage or death. Our long-term goal is to examine the efficacy and mechanisms of dantrolene to treat AD. The overall objective of this study is to investigate the effects and underlying mechanisms of dantrolene to protect against host cell damage or death induced by SARS-CoV-2 spike proteins-mediated overactivation of RyRs and associated Ca2+ dysregulation. Our central hypothesis supported by preliminary data is that dantrolene inhibits SARS-CoV-2 spike proteins-mediated cell damage by inhibiting the overactivation of RyRs and by restoring intracellular Ca2+ homeostasis in AD cells. We will test this hypothesis with the following specific aims. Specific Aim 1 (SA1). To determine the effects of dantrolene on SARS-CoV-2 spike (S) proteins-mediated Ca2+ dysregulation and cell damage by apoptosis in AD cells using induced pluripotent stem cells (iPSC), from skin fibroblasts of patients with either sporadic (SAD) or familial (FAD), and human neuroblastoma cells (SH-SY5Y), with knocked-in AD presenilin 1 mutation (M146L). Specific Aim 2 (SA2). To determine the effects and mechanisms of dantrolene on SARS-CoV-2 spike (S) proteins-mediated pathological pathways leading to host cell damage. We will examine the effects of S proteins on mitochondria oxygen consumption, ATP production, reactive oxygen species (ROS) production, ER stress, and cytokine release. We will correlate the results between SA1 and SA2. We expect that dantrolene will inhibit S proteins-mediated overactivation of RyRs and associated disruption of intracellular Ca2+ homeostasis and cell death by apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
  • 批准号:
    10343664
  • 项目类别:
  • 资助金额:
    $40.25万
  • 财政年份:
    2019
  • 负责人:
    HUAFENG WEI
  • 依托单位:
Mechanisms of Dantrolene Neuroprotection in Alzheimer's Disease
  • 批准号:
    10570995
  • 项目类别:
  • 资助金额:
    $40.25万
  • 财政年份:
    2019
  • 负责人:
    HUAFENG WEI
  • 依托单位:
Mechanisms of anesthesia mediaited neurotoxicity
  • 批准号:
    7929736
  • 项目类别:
  • 资助金额:
    $14.78万
  • 财政年份:
    2009
  • 负责人:
    HUAFENG WEI
  • 依托单位:
Mechanisms of Anesthesia Mediated Neurotoxicity
  • 批准号:
    9022481
  • 项目类别:
  • 资助金额:
    $32.35万
  • 财政年份:
    2008
  • 负责人:
    HUAFENG WEI
  • 依托单位:
国内基金
海外基金
ACE2/AGXT2信号轴在甲基异柳磷诱导斑马鱼神经发育异常过程中的作用机制研究
  • 批准号:
    JCZRLH202600625
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
ACE2 Ser623磷酸化调控MED1促VSMCs功能损伤在移植血管重构中的作用及机制研究
  • 批准号:
    2026JJ50619
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    翁春艳
  • 依托单位:
新型蝙蝠MERS簇冠状病毒HKU5的ACE2细胞受体识别及其分子机制研究
铁皮石斛通过肠道 ACE2 修复 Trp/GPR142 介 导“肠-胰岛 ”轴血糖调控功能的降糖机制研 究
  • 批准号:
    Y24H280055
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    颜美秋
  • 依托单位: